Roberto Güerri-Fernández

11PUBLICATIONS
27CO-AUTHORS
Separation technologiesInnate immunityCardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologiesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 12, 2026
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.

|Jan 28, 2026
Challenges in the Vaccination of HIV-Infected Individuals.

Marta Sisteré-Oró, Roberto Güerri-Fernandez, Montserrat Plana

|Nov 22, 2025
Cross-sectional comparison of cardiovascular risk scores in people with HIV.

Maria Hernandez-Pereira, Juan Du, Jade Soldado-Folgado

|Nov 11, 2024
Impaired Bone Tissue Quality Associated With Inflammation in HIV-immunological Nonresponders: A Cross-sectional Analysis.

Oriol Rins-Lozano, Jaime Rodríguez-Morera, Itziar Arrieta-Aldea

|Oct 11, 2024
Serum-derived bovine immunoglobulin treatment in COVID-19 is associated with faster resolution of symptoms: A randomized pilot clinical trial.

Netanya S Utay, Roberto Güerri-Fernández, Shahin Gharakhanian

|May 25, 2024
Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis.

Valentina Casella, Paula Cebollada Rica, Jordi Argilaguet

Pageof 2

Frequent Collaborators

2 joint publications

Judit Villar-García

2 joint publications

Marta Sisteré-Oró

2 joint publications

Andreas Meyerhans

2 joint publications

Gennady Bocharov